Ligand Pharmaceuticals (LGND) Receivables - Other (2010 - 2015)
Ligand Pharmaceuticals (LGND) reported Receivables - Other of $88000.0 for Q1 2015, down 87.21% on a YoY basis from $688000.0 in Q1 2014, and down 72.67% sequentially from $322000.0 in Q4 2014.
Ligand Pharmaceuticals (LGND) Receivables - Other (2010 - 2015) Analysis & Trends
Ligand Pharmaceuticals (LGND) has 6 years of Receivables - Other data on file, last reported at $88000.0 in Q1 2015.
- For the quarter ending Q1 2015, Receivables - Other fell 87.21% year-over-year to $88000.0; the trailing twelve-month figure through Mar 2015 stood at $88000.0 (down 87.21% YoY), and the FY2014 full-year result was $4.3 million, changed 0.0% from the prior year.
- Receivables - Other retreated to $88000.0 in Q1 2015, from $322000.0 in the prior quarter.
- In the past five years, Receivables - Other ranged from a high of $8.0 million in Q3 2011 to a low of $88000.0 in Q1 2015.
- A 5-year average of $3.8 million and a median of $4.4 million in 2012 frame the typical range for Receivables - Other.
- Across the five-year window, Receivables - Other grew 1.72% in 2013 and sank 92.56% in 2014, its largest moves.
- Tracing LGND's Receivables - Other over 5 years: stood at $6.2 million in 2011, then sank by 30.18% to $4.3 million in 2012, then climbed by 0.05% to $4.3 million in 2013, then slumped by 92.56% to $322000.0 in 2014, then plunged by 72.67% to $88000.0 in 2015.
- Business Quant data shows LGND's Receivables - Other at $88000.0 in Q1 2015, $322000.0 in Q4 2014, and $523000.0 in Q3 2014.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Ligand Pharmaceuticals | 6.05 Bn | 5.27 Bn | 48.45 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2015 | 88,000.00 |
| Mar 31, 2015 | 88,000.00 |
| Dec 31, 2014 | 322,000.00 |
| Dec 31, 2014 | 322,000.00 |
| Sep 30, 2014 | 523,000.00 |
| Sep 30, 2014 | 523,000.00 |
| Jun 30, 2014 | 391,000.00 |
| Jun 30, 2014 | 391,000.00 |
| Mar 31, 2014 | 688,000.00 |
| Mar 31, 2014 | 688,000.00 |
| Dec 31, 2013 | 4.33 Mn |
| Dec 31, 2013 | 4.33 Mn |
| Sep 30, 2013 | 4.51 Mn |
| Sep 30, 2013 | 4.51 Mn |
| Jun 30, 2013 | 4.47 Mn |
| Jun 30, 2013 | 4.47 Mn |
| Mar 31, 2013 | 4.26 Mn |
| Mar 31, 2013 | 4.26 Mn |
| Dec 31, 2012 | 4.33 Mn |
| Dec 31, 2012 | 4.33 Mn |